Identifying diagnostic and prognostic factors in cerebral amyloid angiopathy-related inflammation: A systematic analysis of published and seven new cases

被引:4
|
作者
Szalardy, Levente [1 ,2 ,3 ]
Fakan, Bernadett [1 ]
Maszlag-Torok, Rita [1 ]
Ferencz, Emil [1 ]
Reisz, Zita [4 ,5 ]
Radics, Bence L. [4 ]
Csizmadia, Sandor [6 ]
Szpisjak, Laszlo [1 ]
Annus, Adam [1 ]
Zadori, Denes [1 ]
Kovacs, Gabor G. [2 ,3 ,7 ,8 ]
Klivenyi, Peter [1 ]
机构
[1] Univ Szeged, Albert Szent Gyorgy Clin Ctr, Albert Szent Gyorgy Med Sch, Dept Neurol, Semmelweis U 6, H-6725 Szeged, Hungary
[2] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[3] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada
[4] Univ Szeged, Inst Pathol, Fac Med, Albert Szent Gyorgy Clin Ctr, Szeged, Hungary
[5] Kings Coll Hosp London, Dept Clin Neuropathol, London, England
[6] Affidea Hungary Ltd, Budapest, Hungary
[7] Univ Hlth Network, Lab Med Program, Toronto, ON, Canada
[8] Univ Hlth Network, Krembil Brain Inst, Toronto, ON, Canada
关键词
amyloid-beta-related angiitis; cerebral amyloid angiopathy; cerebral amyloid angiopathy-related inflammation; criteria; diagnosis; inflammatory cerebral amyloid angiopathy; outcome; predictor; BETA-RELATED ANGIITIS; CENTRAL-NERVOUS-SYSTEM; IMAGING ABNORMALITIES; CEREBROSPINAL-FLUID; APOLIPOPROTEIN-E; GRANULOMATOUS-ANGIITIS; ALZHEIMER-DISEASE; 63-YEAR-OLD MAN; ASSOCIATION; CAA;
D O I
10.1111/nan.12946
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aims: Cerebral amyloid angiopathy (CAA)-related inflammation (CAA-RI) is a potentially reversible manifestation of CAA, histopathologically characterised by transmural and/or perivascular inflammatory infiltrates. We aimed to identify clinical, radiological and laboratory variables capable of improving or supporting the diagnosis of or predicting/influencing the prognosis of CAA-RI and to retrospectively evaluate different therapeutic approaches. Methods: We present clinical and neuroradiological observations in seven unpublished CAA-RI cases, including neuropathological findings in two definite cases. These cases were included in a systematic analysis of probable/definite CAA-RI cases published in the literature up to 31 December 2021. Descriptive and associative analyses were performed, including a set of clinical, radiological and laboratory variables to predict short-term, 6-month and 1-year outcomes and mortality, first on definite and second on an expanded probable/definite CAA-RI cohort. Results: Data on 205 definite and 100 probable cases were analysed. CAA-RI had a younger symptomatic onset than non-inflammatory CAA, without sex preference. Transmural histology was more likely to be associated with the co-localisation of microbleeds with confluent white matter hyperintensities on magnetic resonance imaging (MRI). Incorporating leptomeningeal enhancement and/or sulcal non-nulling on fluid-attenuated inversion recovery (FLAIR) enhanced the sensitivity of the criteria. Cerebrospinal fluid pleocytosis was associated with a decreased probability of clinical improvement and longer term positive outcomes. Future lobar haemorrhage was associated with adverse outcomes, including mortality. Immunosuppression was associated with short-term improvement, with less clear effects on long-term outcomes. The superiority of high-dose over low-dose corticosteroids was not established. Conclusions: This is the largest retrospective associative analysis of published CAA-RI cases and the first to include an expanded probable/definite cohort to identify diagnostic/prognostic markers. We propose points for further crystallisation of the criteria and directions for future prospective studies.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] Acute ischemic lesions in cerebral amyloid angiopathy-related inflammation
    Salleles, E.
    Bonneville, F.
    Delisle, M. -B.
    Rigal, E.
    Raposo, N.
    Pariente, J.
    REVUE NEUROLOGIQUE, 2019, 175 (09) : 575 - 577
  • [32] Clinical and radiological features of cerebral amyloid angiopathy-related inflammation
    Gary Álvarez Bravo
    Laura Sánchez Cirera
    Lluís Ramió Torrentà
    Neurological Sciences, 2021, 42 : 5353 - 5358
  • [33] Reversible Periventricular Hyperintensity Lesions in Cerebral Amyloid Angiopathy: A Case Mimicking Cerebral Amyloid Angiopathy-related Inflammation
    Inoue, Yasuteru
    Nakajima, Makoto
    Inatomi, Yuichiro
    Masuda, Teruaki
    Misumi, Yohei
    Nomura, Toshiya
    Uetani, Hiroyuki
    Hirai, Toshinori
    Ueda, Mitsuharu
    INTERNAL MEDICINE, 2022, 61 (23) : 3581 - 3584
  • [34] Cerebral amyloid angiopathy-related inflammation [Zerebrale Amyloidangiopathie assoziiert mit Inflammation]
    Esfahani-Bayerl N.
    Radbruch H.
    Connolly F.
    Der Nervenarzt, 2015, 86 (6) : 748 - 750
  • [35] Multiple cerebral microinfarcts: an uncommon presentation of Cerebral Amyloid Angiopathy-related inflammation
    Theodorou, Aikaterini
    Tsibonakis, Athanasios
    Pateras, Ioannis S.
    Kaloudi, Georgia
    Bakola, Eleni
    Chondrogianni, Maria
    Andreadou, Elissavet
    Panayiotides, Ioannis G.
    Tsivgoulis, Georgios
    NEUROLOGICAL RESEARCH AND PRACTICE, 2023, 5 (01):
  • [37] Clinical Neuropathological Analysis of 10 Cases of Cerebral Amyloid Angiopathy-Related Cerebral Lobar Hemorrhage
    Li, Xiao-Qiu
    Su, Dong-Feng
    Chen, Hui-Sheng
    Fang, Qu
    JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, 2015, 58 (01) : 30 - 35
  • [38] Inflammation in Cerebral Amyloid Angiopathy-Related Transient Focal Neurological Episodes
    Sellimi, Amina
    Panteleienko, Larysa
    Mallon, Dermot
    Fandler-Hofler, Simon
    Oliver, Rupert
    Harvey, Victoria
    Zandi, Michael S.
    Banerjee, Gargi
    Werring, David J.
    ANNALS OF NEUROLOGY, 2025,
  • [40] Cerebral Amyloid Angiopathy-Related Inflammation Biomarkers: Where are we Now?
    Charidimou, Andreas
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 50 (01) : 9 - 11